Female sexual dysfunction. Sexual dysfunction not due to a substance or known physiological condition
Conditions
Interventions
Intervention group: 30 patients were randomly assigned to receive either 30mg dextromethorphan (Soft gelatin capsule dextromethorphan 15mg by Gelocough brand name producted by Dana company) or placebo
Sponsors
Islamic Azad University
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Women aged 18-45 years Confirmed diagnosis of sexual dysfunction according to psychiatric diagnosis and FSFI questionnaire score under 26.55 Having a sexual partner for the last 6 months.
Exclusion criteria
Exclusion criteria: Lack of consent to continue participating in the study. Death of spouse or divorce. Pregnancy and breastfeeding during the study. The presence of severe communication disturbances (such as spousal violence) or other significant stressors that justify sexual problems. Spouse's sexual dysfunction. Menopause (natural or induced by surgery). Addictive disorders. Suffering from neurological and mental diseases such as depression disorders. Taking drugs that interfere with sexual function. Simultaneously suffering from other sexual disorders such as vaginismus, paraphilia and sexual identity disorder. Acute liver disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in female sexual function score base on the female sexual function index (FSFI). Timepoint: before intervention, 4, 9 weeks after intervention. Method of measurement: Female Sexual Function Index (FSFI). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSara Fakharinia
Islamic Azad University
Outcome results
None listed